Abstract
Obesity is commonly associated with type 2 diabetes and vascular disease. Changes in body composition in the obese state lead to a dysregulation of secretion of adipocyte-secreted hormones known as adipokines. Adipokines such as leptin and adiponectin are known to be involved in many physiological and pathological processes. Current knowledge suggests that adipokines provide potential therapeutic targets against type 2 diabetes and vascular disease.
| Original language | English |
|---|---|
| Pages (from-to) | 249-254 |
| Number of pages | 6 |
| Journal | British Journal of Diabetes and Vascular Disease |
| Volume | 12 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Sept 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- adipokines
- leptin
- adiponectin
- vascular disease
- obesity
- type 2 diabetes
Fingerprint
Dive into the research topics of 'Dysregulated adipokines in the pathogenesis of type 2 diabetes and vascular disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver